MissionIR Articles

Cellectar Biosciences, Inc. (NASDAQ: CLRB) is developing agents to detect, treat and monitor a broad spectrum of cancers. With the ability to attach imaging and therapeutic agents to its proprietary delivery platform – a novel…

Protea Biosciences Group, Inc. (OTC: PRGB) is a provider of innovative bioanalytical solutions to the pharmaceutical and life science industries. The company applies its proprietary technology to identify and characterize the proteins, metabolites, lipids and…

Matinas BioPharma Holdings, Inc. (OTC: MTNB) is a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective antifungal and anti-bacterial therapeutics for the treatment of serious and life-threatening infections. The company’s lead anti-infective…

Neuralstem, Inc.’s (NASDAQ: CUR) patented technology enables the commercial-scale production of multiple types of central nervous system (CNS) stem cells, which are being developed as potential therapies for many CNS diseases and conditions. The company…

Citius Pharmaceuticals, Inc. (OTC: CTXR) is a pharmaceutical company developing and commercializing therapeutic products for large and growing markets. Citius uses approved drugs with substantial safety and efficacy data in an effort to reduce the…

Cytori Therapeutics, Inc. (NASDAQ: CYTX) is committed to providing patients and physicians around the world with medical technologies, which harness the potential of adult stem and regenerative cells from adipose tissue. The proprietary Cytori Cell…

Antisense Therapeutics Ltd. (OTC: ATHJF) is an Australian pharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics. One of Antisense Therapeutics’ fundamental strategies is acquiring access to…

ContraVir Pharmaceuticals (NASDAQ: CTRV) is developing targeted antiviral therapies with two drug candidates in clinical studies. The first drug candidate, FV-100, is now in phase 3 trials. It is being developed for the treatment of…

Aytu BioScience, Inc. (OTC: AYTU) is a specialty healthcare company focused on developing and commercializing novel products in the field of urology. Aytu is initially concentrating on prostate cancer, male sexual dysfunction and male infertility…

Ceapro, Inc. (OTC: CRPOF) is a Canadian biotechnology company with headquarters in Edmonton, Alberta. Through the use of proprietary technology and renewable and sustainable resources, Ceapro is focused on becoming a global leader in developing…

NephroGenex, Inc. (NASDAQ: NRX) is an innovator in the development of drugs to treat kidney disease with a first indication in diabetic nephropathy. It has been pioneering the development of PYRIDORIN (pyridoxamine dihydrochloride), a late…

Bio-Path Holdings, Inc. (NASDAQ: BPTH) is a biotechnology company focused on developing therapeutic products utilizing DNAbilize™, its proprietary liposomal delivery and antisense technology, to systematically distribute nucleic acid drugs throughout the human body with a…

Benitec Biopharma (NASDAQ: BNTC) has developed a breakthrough platform for treating human diseases called DNA-directed RNAi (ddRNAi). Unlike other RNAi-based technologies, ddRNAi effects lasting change in target cells, leading to long term benefits and, potentially,…

Navidea Biopharmaceuticals (NASDAQ: NAVB) envisions a world where disease can be precisely identified and treated. Navidea is a leader in precision medicine with products  designed to help identify the sites and pathways of  undetected disease…

Biosig Technologies (OTC: BSGM) is a development stage medical device company that engages in developing technology platforms for the purposes of reducing noise from cardiac recordings during electrophysiology studies. The company’s main product under development…

DelMar Pharmaceuticals, Inc. (OTC: DMPI) is a clinical and commercial stage drug development company with a focus on the treatment of cancer. The company is in the midst of conducting clinical trials in the U.S.…

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is focused on the invention and development of novel pharmaceutical products for medical conditions that it believes have broad societal impact, and that are not well served by currently available…

BioLife Solutions, Inc. (NASDAQ: BLFS) is located in Bothell, Washington, on a high-tech campus that has roots as a dairy farm. The company manufactures and markets proprietary protein-free, serum-free cGMP biopreservation media for cells, tissues…

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is on a quest to expand immune system stimulation to revolutionize the fight against cancers and infectious diseases. Stimulating the body’s immune system remains one of the most promising approaches…

Chembio Diagnostics, Inc. (NASDAQ: CEMI) is committed to delivering exceptional products that provide ease of use, and rapid and accurate results at the point-of-care (POC). At the core of its commitment is its patented Next…